As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
Building Blocks to Better IBD Veteran Patient Care: The APP Perspective
Malnutrition and Inflammatory Bowel Disease (IBD)
APP Biosimilar Education Video Series Module 2
APP Biosimilar Education Video Series Module 3
APP Biosimilar Education Video Series Module 4
Ross M. Maltz, MD
PeerAPP Biosimilar Education Video Series Module 1
Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
Exploring the DINE-CD Study & the Importance of Diet for IBD Patients
Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis
Jordan E. Axelrad, MD, MPH
PeerKeeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
Xiaohong Wang, MD, PhD
PeerCrohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being
Tina Aswani Omprakash
PeerCrohn’s & Colitis Congress 2021: The Future of IBD Treatments